This is a preview of subscription content, log in via an institution to check access.
Notes
2015 Australian dollars
Reference
de Graaff B, et al. Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model. PharmacoEconomics-Open : 16 Nov 2016. Available from: URL: http://dx.doi.org/10.1007/s41669-016-0005-0
Rights and permissions
About this article
Cite this article
Model of haemochromatosis screening developed. PharmacoEcon Outcomes News 767, 19 (2016). https://doi.org/10.1007/s40274-016-3579-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3579-y